Mucomyst Related Published Studies
Well-designed clinical trials related to Mucomyst (Acetylcysteine Inhalation)
The Effects of N-Acetylcysteine and Deferoxamine on Plasma Cytokine and Oxidative Damage Parameters in Critically Ill Patients With Prolonged Hypotension: A Randomized Controlled Trial. [2011.11.01]
Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: A randomized controlled trial. [2011.09]
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia. [2011.07]
A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. [2011.05.03]
Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury. [2011.05]
N-acetylcysteine in handgrip exercise: plasma thiols and adverse reactions. [2011.04]
Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. [2011.04]
Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study. [2011.04]
The role of preconditioning and N-acetylcysteine on oxidative stress resulting from tourniquet-induced ischemia-reperfusion in arthroscopic knee surgery. [2011.03]
Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? [2011]
Qualitative methods in early-phase drug trials: broadening the scope of data and
methods from an RCT of N-acetylcysteine in schizophrenia. [2011]
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. [2010.12]
Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction. [2010.12]
Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS-A multicenter prospective controlled trial. [2010.11.22]
Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy Chinese male volunteers. [2010.11]
N-acetylcysteine does not prevent renal dysfunction after off-pump coronary artery bypass surgery. [2010.11]
Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial. [2010.10]
N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. [2010.10]
Intraoperative pH values after N-acetylcysteine administration during liver transplantation. [2010.10]
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. [2010.10]
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia. [2010.09.21]
Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. [2010.09]
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. [2010.09]
Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial. [2010.08.01]
Efficacy of topical N-acetylcysteine in the treatment of meibomian gland dysfunction. [2010.08]
The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy. [2010.07]
N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation. [2010.07]
Preventing cisplatin induced ototoxicity by N-acetylcysteine and salicylate. [2010.07]
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. [2010.07]
Effects of N-acetylcysteine on asthma exacerbation. [2010.06]
Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. [2010.05.18]
N-Acetylcysteine infusion does not affect glucose disposal during prolonged moderate-intensity exercise in humans. [2010.05.01]
N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis. [2010.05]
Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. [2010.05]
Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operation. [2010.04]
Efficacy of N-acetylcysteine and aminophylline in preventing contrast-induced nephropathy. [2010.03]
Modulatory effect of N-acetylcysteine on pro-antioxidant status and haematological response in healthy men. [2010.03]
N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients. [2010.01]
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. [2010]
Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. [2010]
N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in
patients undergoing orthotopic liver transplantation. [2010]
N-Acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial. [2009.12.26]
Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. [2009.11]
Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study. [2009.10]
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. [2009.09]
N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy. [2009.09]
Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. [2009.09]
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis. [2009.08.12]
Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. [2009.08]
N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. [2009.07]
Potentially detrimental effects of N-acetylcysteine on renal function in knee arthroplasty. [2009.07]
Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. [2009.07]
N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. [2009.06.29]
N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. [2009.06]
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis. [2009.04]
N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. [2009.03]
The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. [2009.03]
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. [2009.02]
Effects of N-acetylcysteine on respiratory muscle fatigue during heavy exercise. [2009.01.01]
Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. [2009.01]
Blood cardioplegia with N-acetylcysteine may reduce coronary endothelial activation and myocardial oxidative stress. [2009.01]
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial. [2009.01]
N-acetylcysteine improves arterial vascular reactivity in patients with chronic kidney disease. [2009]
The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males. [2009]
Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance to N-acetylcysteine supplementation. [2008.12]
The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery. [2008.12]
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? [2008.12]
N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. [2008.11]
Effect of N-acetylcysteine administration on intraoperative plasma levels of interleukin-4 and interleukin-10 in liver transplant recipients. [2008.11]
N-acetylcysteine supplementation and oxidative damage and inflammatory response after eccentric exercise. [2008.08]
Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. [2008.08]
Meta-analysis of N-Acetylcysteine to Prevent Acute Renal Failure After Major Surgery. [2008.07.21]
Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. [2008.07]
Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. [2008.06.06]
Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. [2008.06.01]
Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease. [2008.06.01]
Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. [2008.06]
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. [2008.05]
N-Acetylcysteine does not artifactually lower plasma creatinine concentration. [2008.05]
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. [2008.05]
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results. [2008.04]
Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients. [2008.01]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. [2008.01]
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study. [2008]
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. [2007.12]
N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. [2007.11]
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial* [2007.10.16]
Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. [2007.10]
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. [2007.09]
I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. [2007.09]
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect. [2007.09]
Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. [2007.09]
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. [2007.08]
Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans. [2007.08]
Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. [2007.05]
Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. [2007.05]
The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. [2007.03.27]
Randomized, double-blind, placebo-controlled trial of Intravenous (n-acetylcysteine, selenium, vitamin c) Antioxidant therapy in severe acute pancreatitis. [2007.03.13]
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy : The Dialysis-versus-Diuresis (DVD) Trial. [2007.03]
Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. [2007.01.31]
Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. [2007.01]
|
